Follow us twitter facebook
Edition: Global
Click here to subscribe toour free weekly newsletter click here
Companies & industry

Formulation: Nippon Shikizai invests in France

The Japanese firm Nippon Shikizai Inc., specialized, among other things, in the manufacture of skin care and make-up formulas (63 million euros in sales with a workforce of 235 people) continues to invest in its French subsidiary she had acquired in 2000, the company Thépenier Pharma Industrie (8.5 million euros in sales for a staff of 80), based in Saint-Langis-Lès-Mortagne (Normandy region).

After spending in France 6.2 million euros in 2003 in a brand new production facility intended to host the colour cosmetic activity, the company has just commissioned its first machine called "back injection", which enables the manufacturing of compacts and/or eye shadows in automatic or by injecting directly up to four different shades and/or textures through the base of the pans.

Since October 15th the company Thépenier Pharma Industrie, a subsidiary of the Japanese Group Nippon Shikizai, is able to produce compact and/or eye shadow under this new technique called "Back injection". "Main assets, explains Sylvie Coudray, Sales manager of Thépenier Pharma Industrie, an extensive experience in the conditioning of colour cosmetics, in packaging, the possibility to inject several colours and/or textures simultaneously, the design of extremely varied patterns since it is possible to inject in a hollow imprint, and ultimately, achieve very high quality products, especially products with glitters." Not forgetting, of course, a substantial improvement in productivity.

Technology transfers with Japan

After acquiring the French company in 2000, the Japanese group is demonstrating its determination to conquer the European industry of colour cosmetics.

Colour cosmetics, a segment, that its leaders know well. Founded in 1957 Nippon Shikizai employs more than 230 people and achieves about half of its turnover in this segment. Fifty people work daily in the R&D department.

Since the acquisition of Thépenier Pharma Industrie, there has been a great deal of technology transfers between the two companies, especially in the field of the production of compact and fluid foundations, of mascara and lip gloss.

The new production unit dedicated to this activity which was built in 2003 in Saint-Langis-Lès-Mortagne, in Normandy, will have cost the hefty sum of 6.2 million euros and investments have not stopped with the acquisition of this new so-called "Back Injection" machine.

"To note that in a different domain, explains Coudray, we have also acquired a real expertise in the production of BB creams (BB for blemish balm. A cream that nourishes, soothes, conceals red spots and protects against sun burns. The BB cream has several functions. It hydrates, unifies, refines skin texture and conceals imperfections)".

Jean-Yves Bourgeois

© 2011 - Premium Beauty News -
latest news

MakeUp in Paris: The countdown has started before the 2020 edition

The next edition of the BtoB trade show dedicated to the make-up and skincare value chain will be held on June 18th and 19th at the Carrousel du Louvre. Once again, MakeUp in Paris will gather key suppliers of packaging, formulation and full-service solutions for the make-up and skincare markets. The event will feature: latest (...)

read more
job opportunities
Experts’ views
On center stage, the floral bouquet is making its come back

Émilie Coppermann
On center stage, the floral bouquet is making its come back

Just like fashion that is eternally being reinvented, perfumery also works in cycles. And the floral accord is no exception. The very essence of femininity, today floral fragrances are less invasive than in the 1980s, as was the case with Poison by Christian Dior. At the end of the 1990s, floral accords were replaced by clean musky (...)

read more


We use cookies to give you a better browsing experience. By continuing your visit to this site, you accept the use of cookies. Read more and set cookies